Zhong et al. demonstrated that the RARS-mitotic arrest deficient-like 1 (MAD1L1) fusion protein interacted with AIMP2 to increase the expression of FBP, thereby promoting the occupation of the c-Myc promoter by FBP and subsequently inducing cancer stem cell (CSC)-like properties89. The gene discussed is MYC; the disease is cancer.